Responses of patients with Bartter's syndrome to angiotensin III and angiotensin II-(3-8)-hexapeptide.

T. Kôno; F. Ikeda; A. Taniguchi; H. Imura; F. Oseko; M. Yoshioka; M. Khosla

DOI:10.1530/ACTA.0.1090249

Corpus ID: 42181498

Responses of patients with Bartter's syndrome to angiotensin III and angiotensin II-(3-8)-hexapeptide.

@article{Kno1985ResponsesOP,
  title={Responses of patients with Bartter's syndrome to angiotensin III and angiotensin II-(3-8)-hexapeptide.},
  author={T. K{\^o}no and F. Ikeda and A. Taniguchi and H. Imura and F. Oseko and M. Yoshioka and M. Khosla},
  journal={Acta endocrinologica},
  year={1985},
  volume={109 2},
  pages={
          249-53
        }
}

T. Kôno, F. Ikeda, +4 authors M. Khosla

Published 1985

Medicine

Acta endocrinologica

Studies were conducted to determine whether or not angiotensin III [AIII] and angiotensin II-(3-8)-hexapeptide [ANG-(3-8)] have their own specific arteriolar binding sites different from angiotensin II [AII] binding site(s) in man. Four patients with Bartter's syndrome were given asn1-,val5-AII by iv infusion at rates of 10, 20, 50 and 100 pmol/kg X min, each for 7 min. One hour later AIII was infused iv in the same 4 patients at rates of 50, 100, 250 and 500 pmol/kg X min, each for 7 min… CONTINUE READING

View on PubMed